Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
September 26, 2018	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001144204-18-050920.pdf 0001144204-18-050920.rtf 0001144204-18-050920.xls View HTML
October 1, 2018	S-4	Registration of securities issued in business combination transactions	0001193125-18-288504.pdf 0001193125-18-288504.rtf 0001193125-18-288504.xls View HTML
October 1, 2018	8-K	Report of unscheduled material events or corporate event	0001193125-18-288497.pdf 0001193125-18-288497.rtf 0001193125-18-288497.xls View HTML
October 2, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-290314.pdf 0001193125-18-290314.rtf View HTML
October 18, 2018	UPLOAD	UPLOAD	0000000000-18-032657.pdf 0000000000-18-032657.rtf View HTML
October 25, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-307890.pdf 0001193125-18-307890.rtf 0001193125-18-307890.xls View HTML
October 25, 2018	CORRESP	CORRESP	0001193125-18-307903.pdf 0001193125-18-307903.rtf 0001193125-18-307903.xls View HTML
October 26, 2018	UPLOAD	UPLOAD	0000000000-18-033597.pdf 0000000000-18-033597.rtf View HTML
October 29, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-309873.pdf 0001193125-18-309873.rtf 0001193125-18-309873.xls View HTML
October 29, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-310776.pdf 0001193125-18-310776.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax